In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary regenerative capacity to repair or compensate for it. Once this "point of no ...
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...
A machine learning (ML) tool that analyses electronic health record data, test results, and patient demographics can help clinicians identify people at high risk of hepatocellular carcinoma (HCC), the ...